Min Li to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications Min Li has written about Drug Screening Assays, Antitumor.
Connection Strength
0.086
-
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
Score: 0.046
-
An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A. 2019 11 12; 116(46):23264-23273.
Score: 0.040